... drug delivery systems are needed. Porous silicon nanoparticles (pSiNPs) are an attractive drug delivery system due to their high surface area, biodegradability, and tuneable porosity, although challenges with uncontrolled degradation, limited circulation time, and inefficient drug release remain...

... can be incorporated into polymers or directly into the stent surfaces, from which they would slowly release the drug at the stent installation site. 11 There are only few studies of PEO-based drug-delivery systems available. In most of these studies, polymers have been used as drug carriers...

... to several side effects. In order to eliminate or decrease them, alternative ways of administration using different drug delivery systems (DDS) are extensively investigated. Some formulations, such as liposomal DOX, are already on the market, while other conjugates have currently the clinical trial status...

... biomaterial bone cell–surface interaction drug delivery regeneration scaffold soft tissue tissue engineering A body is equipped with native defense and regenerative mechanisms that center on the ability of cells to target foreign bodies, infected cells and injured tissues. At the heart of cell...